UPDATE 1-Galenica to buy biotech firm Relypsa for $1.5 bln before break-up
July 21, 2016 at 03:30 AM EDT
July 21 (Reuters) - Galenica has agreed to buy U.S. biotech firm Relypsa for $1.53 billion in cash to strengthen its Vifor Pharma unit ahead of splitting up the Swiss healthcare group.